Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing Funding Will Accelerate FDA Submission and Commercialization of Automated Benchtop Blood Testing System TYH Ventures, Glen Tullman of 7WireVentures, and Wittington Ventures Led the Round, Joined by General Catalyst, GreatPoint Ventures, DNS Capital, and Wasson Enterprise Prominent Industry Leaders Join Executive Team and Board of Directors News provided by Share this article Share this article SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- Truvian Sciences ("Truvian") today announced the close of more than $105 mi...
Source: prnewswire.com